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In the course of a continuing series of clinical trials of various chemical compounds in
search of a more efficient treatment for tinea capitis, a proprietary substance designated
by the term "Ro 2-520S"t in the form of a carbowax ointment containing 1% of the drug,
was administered topically to the scalps of 92 children for several weeks. Beginning as
early as the 14th day 12 patients (13.0%) exhibited partial loss of hair distributed diffusely
throughout the scalp. Upon continuation of this therapy further depilation was induced in
all of these individuals proceeding to practical totality (Figure 1).
In three additional patients (3.3%), in whom the fungous infection was limited to well
defined patches which were consequently the only areas medicated, a similar process was
observed; in all of these the epilation occurred only in and about these areas. It is thus our
impression at this time that the action of the drug was local instead of systemic in this
regard.
The defiuvium began as early as the end of the second week of therapy and as late as the
end of the sixth week; it was usually completed rapidly in the next 7 to 12 days. Upon with-
drawal of the drug the hair began to grow again in from two to five weeks in all instances.
In the earlier cases it has returned entirely to normal; the remainder of the patients are
also regaining hair in a satisfactory manner.
This phenomenon occurred without significant statistical variation because of sex, race,
age, type of fungous infection or the organism involved, its severity or duration before
treatment was begun, or the amount of the medicament applied. There were 11 males and 4
females; 11 of the 15 were Negroes, and the ages of the patients varied from one and one
half to 12 years. These proportions are approximately the same as in the entire group of 92
cases. Five patients were infected with M. audouini, four with M. lanovurn and four with
T. tonsurans; there were two patients in whom the organism was not culturally identified.
Again, these figures closely adhere to the percentages in which these infections are en-
countered in our clinics.
Subsequently, careful cultural and microscopic studies revealed that all but one of the
patients who had experienced total depilation had been entirely cured of the fungous in-
fection. The exceptional case (which was infected by AT. lanosum) had been improved about
90%. When this beneficial trend became evident, it seemed useful to attempt to raise the
percentage of total depilations by more liberal use of the compound. No significant increase
has been observed however with this method while using the original concentration (1%);
experiments with higher percentages are in process.
Because this work in general is progressing slowly and cautiously, with many lapses in
the use of the drug, we are not, as yet, ready to state our conclusions as to its antifungal
efficiency in those cases in which epilation does not occur. At the present time it seems to be
better than other drugs in T. tonsurans infections, not significantly different in those caused
by M. andouini, and perhaps less effective in those due to M. lanosurn.
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COMMENT ON CHEMISTEY
The base of the drug under discussion is chemically p-(betadiethylamino-ethoxv) phenyl-
phenethyl ketone. In the trials described, both the oxalate (Ro 2-5208) and the citrate
(Ro 2-5208/1) were used in a concentration of 1% as a carbowax ointment. The oxalate
occurs as white crystals having a melting point of 63 to 67°C and the citrate as off-white
Fin. 1
crystals having a melting point of 116 to 118°C. Both salts are soluble in water (1). The
structural formula of the base is as follows:
C2H5
C2H5
RH
It is interesting to note that this compound does not exhibit the —C=C— chemical group
"designated" by Flesch and Goldstone (2) as the "active grouping" responsible for depila-
tion in their original studies of the cyclic dimers of neoprene, the 18 unsaturated compounds
subsequently tested by them as well as Vitamin A and squalene.
Note: Subsequent to the completion of this manuscript temporary depilation of the same
diffuse type and proceeding to about 75% of totality has occurred in two adults, one woman
and one man, from administration of the drug to the feet and hands, but not to the scalp.
It is apparent that the systemic absorption of the drug is an important mechanism in depila-
tion which did not become evident in the series of children treated for tinea capitis except
for the observation that eyebrows and lashes were lost in some instances. Our impression
that this occurred because of unintentional transfer of the drug to the eyebrow area was
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evidently not the only explanation. It seems likely that the drug can produce depilation by
both the local and the systemic absorption mechanisms.
Clinical trials of this substance have been suspended until these phenomena may be
clarified by animal experimentation.
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